Get started
AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AMGND chart


Full chart

Key stats


Market capitalization
‪154.74 B‬ USD
Dividend yield (indicated)
2.84%
Price to earnings Ratio (TTM)
42.078
Basic EPS (TTM)
0.260 USD
Net income (FY)
‪2.45 B‬ USD
Revenue (FY)
‪10.20 B‬ USD
Shares float
—
Beta (1Y)
0.40

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
FIGI
BBG000HDW649
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AMGND news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGND highest yielding bonds


AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
6.94%
Maturity date
Sep 1, 2053
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
6.47%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.44%
Maturity date
Feb 21, 2050
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
6.37%
Maturity date
Aug 15, 2041
US31162CR9
AMGEN 20/40
Yield to maturity
6.33%
Maturity date
Feb 21, 2040
US31162DG2
AMGEN 22/62
Yield to maturity
6.28%
Maturity date
Feb 22, 2062
US31162BP4
AMGEN 12/43
Yield to maturity
6.25%
Maturity date
May 15, 2043
AMGD
AMGEN 22/52
Yield to maturity
6.25%
Maturity date
Feb 22, 2052
US31162BZ2
AMGEN 15/45
Yield to maturity
6.15%
Maturity date
May 1, 2045
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
6.08%
Maturity date
Jun 15, 2048
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
6.03%
Maturity date
Jun 15, 2051

Explore more bonds 

Sparks


Curated watchlists where AMGND is featured.

See all sparks